CA
NZ
UK
AU
IND
US
Director James N. Wilson filed a Form 4 with the SEC on August 18, 2026, disclosing the sale of 10,000 shares of Corcept Therapeutics common stock on August 14, 2026, executed under a pre-established 10b5-1 trading plan.
Randall A. Lipps, Chairman and Chief Executive Officer of Omnicell, Inc., filed a statement of changes in beneficial ownership with the SEC on August 18, 2026, disclosing a tax-withholding transaction in common stock dated August 15, 2026.
Sean Maduck, President of Corcept Endocrinology at Corcept Therapeutics Incorporated (NASDAQ:CORT), filed a Form 4 on August 18, 2026, disclosing transactions in the company's common stock dated August 14, 2026.
Nnamdi Njoku, President and Chief Operating Officer of Omnicell, Inc. (NASDAQ:OMCL), filed a Form 4 on August 18, 2026, disclosing two transactions in the company's common stock dated August 15 and August 17, 2026.
Brian H. Nutt, VP and Chief Accounting Officer of Omnicell, Inc. (NASDAQ:OMCL), filed a Form 4 on August 18, 2026, reporting a share withholding transaction and an Employee Stock Purchase Plan acquisition dated August 15, 2026.
Steven C. Crouse, President of Diagnostics and Spatial Biology at BIO-TECHNE Corp (NASDAQ:TECH), filed a Form 4 on August 18, 2026, reporting transactions in common stock dated August 15, 2026, including the vesting of restricted stock units and a related share withholding.
A Form 4 filed on August 18, 2026 discloses that Daniel Leib, Chief Executive Officer and Director of Donnelley Financial Solutions, Inc., sold 213 shares of common stock on August 14, 2026.
Martine A. Rothblatt, Chairperson and CEO of United Therapeutics Corp, filed a Form 4 on August 18, 2026, disclosing the exercise of stock options and sale of common stock on August 17, 2026, pursuant to a pre-arranged Rule 10b5-1 trading plan.
A Form 4 filed with the SEC on August 18, 2026, disclosed that Edward D. Breen, a director of Comcast Corp (NASDAQ:CMCSA), transferred 62,440 shares of Class A Common Stock to a grantor retained annuity trust (GRAT) on August 17, 2026.
Dustee Jenkins, Chief Public Affairs Officer of Spotify Technology S.A. (NYSE:SPOT), filed a Form 4 on August 18, 2026, disclosing a series of transactions in Ordinary Shares and a stock option exercise dated August 14, 2026.
Please wait processing your request...